WebDisclosure WebDisclosure
Basculer en Français
10964 Companies
239965 Keywords
168734 Articles
129106 Press releases
Headlines Articles Press releases Cibolo Energy Partners Remove
  1. Home
  2. Companies
  3. Cibolo Energy Partners
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 09/10/2024 at 01:05, 2 years ago

    Cibolo Energy Partners Announces Final Closing on $279 Million Cibolo Energy Partners II, L.P.

    Growth Capital Cibolo Energy Partners $279 Million Fund Upstream And Midstream Private Debt Firm
  • BRIEF

    published on 09/10/2024 at 01:05, 2 years ago

    Cibolo Energy Partners annonce la clôture définitive de 279 millions de dollars pour Cibolo Energy Partners II, LP

    Capital De Croissance Partenaires Énergétiques De Cibolo Fonds De 279 Millions De Dollars En Amont Et Au Milieu Du Parcours Société De Dette Privée
  • PRESS RELEASE

    published on 09/10/2024 at 01:00, 2 years ago

    Cibolo Energy Partners Announces Final Closing on $279 Million Cibolo Energy Partners II, L.P.

    Cibolo Energy Management, LLC announced the closing of Fund II, a $279 million private debt fund for energy companies. Focus on growth-oriented credit solutions
    Fund II Growth Capital Private Debt Firm Cibolo Energy Management Energy Companies
    Logo of Cibolo Energy Partners
Accesswire
  • Published on 09/11/2026 at 04:00, 2 hours 32 minutes ago

    Torq Announces Debt Settlement and Corporate Update

  • Published on 09/10/2026 at 22:25, 8 hours 7 minutes ago

    Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer

  • Published on 09/10/2026 at 17:46, 12 hours 46 minutes ago

    Groete Access Road Nears Completion

  • Published on 09/10/2026 at 15:20, 15 hours 12 minutes ago

    MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026

  • Published on 09/10/2026 at 15:00, 15 hours 32 minutes ago

    All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

View all ACCESSWIRE
EQS Group
  • Published on 09/11/2026 at 00:05, 6 hours 27 minutes ago

    Club Offers for Travel Enthusiasts in Germany

  • Published on 09/11/2026 at 00:01, 6 hours 31 minutes ago

    Club Offers for Travel Enthusiasts in Germany

  • Published on 09/10/2026 at 22:39, 7 hours 52 minutes ago

    EQS-Adhoc: Notice by Rumble Deutschland AG regarding an upcoming squeeze-out under German Stock Corporation Law

  • Published on 09/10/2026 at 22:10, 8 hours 21 minutes ago

    flatexDEGIRO with changes to the Supervisory Board

  • Published on 09/10/2026 at 22:07, 8 hours 25 minutes ago

    EQS-Adhoc: flatexDEGIRO SE: Changes to the Supervisory Board

View all EQS
Les Echos
  • Published on 09/10/2026 at 19:30, 11 hours 2 minutes ago

    Availability of the 2026 Interim Financial Report

  • Published on 09/10/2026 at 19:30, 11 hours 2 minutes ago

    Mise à disposition du Rapport Financier Semestriel 2026

  • Published on 09/10/2026 at 18:10, 12 hours 22 minutes ago

    LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 août 2026

  • Published on 09/10/2026 at 17:45, 12 hours 47 minutes ago

    COGRA : RÉSULTATS ANNUELS 2025/26 - Retour à la croissance rentable et structure financière renforcée

  • Published on 09/10/2026 at 17:42, 12 hours 49 minutes ago

    Déclaration d'actions et de droits de vote au 31.08.2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy